The content on this site is intended for healthcare professionals only
Different perspectives shaping the HARMONY project
Published: 5 Jan 2018
Views: 1797
Patricia Van Dijck - Novartis
Patricia Van Dijck talks to ecancer at EAPM 2017 in Belfast.
She discusses the Harmony Project and the importance of having multi-stakeholder perspectives accounted for.
Related Videos
Real world evidence on the use of antibody drug conjugates in peripheral T-cell ...
Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Leba...
14 Jun 2021
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC
Dr Christina Baik - University of Washington School of Medicine, Seattle, USA
11 Jun 2021
ELEVATE-TN: Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in t...
Dr Jeff Sharman - Willamette Valley Cancer Institute, Eugene, USA
11 Jun 2021
CAPTIVATE: Fixed-duration first-line treatment with ibrutinib plus venetoclax fo...
Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey/RWJBarnabas Health, N...
10 Jun 2021
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...
Dr Terence Friedlander - UCSF, San Francisco, USA
4 Jun 2021
The problems in cancer care, research and treatment in Romania
Dr Mihai Marinca - Regional Oncology Institute, Iași, Romania
19 Jan 2021
Key themes, highlights and importance of this year's IBCD 2020 meeting
Dr Roberto Salgado - Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgiu...
29 Oct 2020
Breast Cancer at ASCO 2020 - AORTIC African Cancer Dialogues
Host: Dr. Miriam Mutebi, Speakers: Dr. Verna Vanderpuye, Dr. Sitna Mwanzi
6 Aug 2020
The European Cancer Prevention Organization
Prof. Jaak Janssens - Hasselt, Belgium
22 Jul 2020
